glp-1 treatment for pre-diabetes GLP−1 receptor agonists the of obesity: Role as a promising approach GLP-1 Receptor Agonists | New

Include leafy greens (spinach, kale, rocket), cruciferous vegetables (broccoli, cauliflower, Brussels sprouts), courgettes, peppers, tomatoes, and mushrooms

Typically, GLP-1 receptor agonists are recommended for individuals with a BMI of 30 kg/m or higher, classified as obesity, or for those with a BMI of at least 27 kg/m who also have obesity-related health conditions such as hypertension, type 2 diabetes , or high cholesterol

The physicochemical characteristics, the cytoarchitecture, and the mucociliary clearance of the nasal mucosa are essential criteria

In randomized trials among people with Type 2 diabetes, the drugs achieved HbA1c reduction of at least an absolute 2 percentage points which led to their FDA approvals (For semaglutide in January 2020, and for tirzepatide in May 2022)

For thousands of years, this herb has been used in traditional Chinese medicine to treat diabetes